Methods and Systems for Generating Nanoparticles
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application 61/317,783, filed Mar 26, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,207,290 | Methods and Systems for Generating Nanoparticles In force · High confidence | Cerulean Pharma Inc. | In force | High confidence | ||
| US 8,618,240 | Methods and Systems for Generating Nanoparticles In force · Medium confidence | Cerulean Pharma, Inc. | In force | Medium confidence | ||
| Application 14/144,289 | Methods And Systems For Generating Nanoparticles Abandoned Abandoned Oct 13, 2015 | Cerulean Pharma Inc. | Abandoned | Abandoned Oct 13, 2015 |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Cerulean Pharma Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.